CHINA REGENERATIVE MEDICINE INTERNATIONAL LIMITED

China Regenerative Medicine International Limited

8158

KYG2129W1380

Medical Equipment, Supplies & Distribution

Delayed Hong Kong S.E. Other stock markets 04:08:22 2024-04-29 am EDT			5-day change	1st Jan Change
0.285 ^HKD	+5.56%		+1.79%	-48.18%

Apr. 02	China Regenerative Medicine International Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	China Regenerative Medicine International Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

China Regenerative Medicine International Limited Announces the Cessation of Lee Pak Chung as Chief Financial Officer

June 01, 2021 at 07:17 am EDT

China Regenerative Medicine International Limited announced that due to work arrangement, with effect from 1 June 2021, Mr. Lee Pak Chung will cease to be the chief financial officer of the company.

Latest news about China Regenerative Medicine International Limited

China Regenerative Medicine International Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
China Regenerative Medicine International Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
China Regenerative Medicine International Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
China Regenerative Medicine International Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
China Regenerative Medicine International Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-10	CI
China Regenerative Medicine International Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-11	CI
China Regenerative Medicine International Limited Announces CFO Change	22-09-01	CI
China Regenerative Medicine International Limited Announces Executive Changes	22-09-01	CI
China Regenerative Medicine International Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-12	CI
China Regenerative Medicine International Limited Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-13	CI
China Regenerative Medicine International Limited Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-31	CI
China Regenerative Medicine International Limited Announces Delay in Publication of Audited Annual Results for the Year Ended 31 December 2021	22-03-25	CI
China Regenerative Medicine International Limited Announces Board Changes	21-12-29	CI
China Regenerative Medicine International Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-12	CI
China Regenerative Medicine International Limited Announces Executive Changes	21-08-31	CI
China Regenerative Medicine International Limited Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-13	CI
China Regenerative Medicine International Limited Announces the Cessation of Lee Pak Chung as Chief Financial Officer	21-06-01	CI
China Regenerative Medicine International Limited Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-14	CI
China Regenerative Medicine International Limited Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-31	CI
China Regenerative Medicine International Limited Enters into Non-Legally Binding Memorandum of Understanding with Jinxin Holdings Co, Ltd	21-03-22	CI
Link Asia International MedTech : to Form Stem Cell Storage JV with Chinese Firm	21-03-19	MT
China Regenerative Medicine International Limited Announces Management Changes	20-12-29	CI
China Regenerative Medicine International Limited Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-11	CI
China Regenerative Medicine International Limited Announces Address Change	20-10-12	CI
China Regenerative Medicine International Limited Announces Change of Head Office and Principal Place of Business in Hong Kong	20-09-04	CI

Chart China Regenerative Medicine International Limited

Duration

Period

Chart China Regenerative Medicine International Limited

More charts

China Regenerative Medicine International Ltd is an investment holding company mainly engaged in the provision of comprehensive health products and services. The Company is engaged in the supply and sale of medical products and medical equipment. In addition, the Company is engaged in the provision of various health management services such as health assessment, detoxification treatment, homeostasis, organ maintenance and immune system enhancement.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-09 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
CHINA REGENERATIVE MEDICINE INTERNATIONAL LIMITED	-48.18%	10.49M
ABBOTT LABORATORIES	-2.54%	187B
MEDTRONIC PLC	-1.85%	106B
BECTON, DICKINSON AND COMPANY	-4.26%	66.9B
DEXCOM, INC.	+1.39%	49.45B
CENCORA, INC.	+16.82%	48B
HOYA CORPORATION	+5.76%	40.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+3.49%	26.48B
WEST PHARMACEUTICAL SERVICES, INC.	+0.65%	26.25B
TERUMO CORPORATION	+17.57%	24.62B